Skip to content

Medical emergency? What to do

Loss of “Guardian Angel” Gene Prompts Premature Birth

3-RXPublished February 2, 20105 min read

Key points

  • Mutation of a gene that helps protect the body from genetic instability leads to cellular and molecular changes in the pregnant uterus that trigger premature birth, according to a study appearing online Feb.
  • “Preterm birth and prematurity are problems that pose huge long-term social and economic liabilities, and there is an urgent need for research with new approaches to combat this public health concern,” Dr.
  • In the current study, researchers targeted certain signaling pathways that function both in pregnancy and during the formation of cancerous tumors.
  • The researchers wanted to test the importance of uterine p53 in female reproduction, but the availability of suitable mouse models for clinically relevant preterm labor studies is limited.

Mutation of a gene that helps protect the body from genetic instability leads to cellular and molecular changes in the pregnant uterus that trigger premature birth, according to a study appearing online Feb. 1 in the Journal of Clinical Investigation.

The research by scientists in the Division of Reproductive Sciences, part of the Perinatal Institute at Cincinnati Children’s Hospital Medical Center, sheds new light on the still poorly understood genetic and physiological reasons for preterm births. The findings could help lead to the development of new strategies for treating and preventing prematurity, according to Sudhansu K. Dey, Ph.D., director of Reproductive Sciences at Cincinnati Children’s and the study’s senior investigator.

“Preterm birth and prematurity are problems that pose huge long-term social and economic liabilities, and there is an urgent need for research with new approaches to combat this public health concern,” Dr. Dey said.

Premature birth is responsible for 30 percent of all neonatal deaths, is a significant cause of long-term disability, and costs $26 billion a year in the United States, according to estimates from the National Academy of Sciences’ Institute of Medicine.

In the current study, researchers targeted certain signaling pathways that function both in pregnancy and during the formation of cancerous tumors. Signaling pathways are chains of molecular interactions that promote cellular communication. During pregnancy, the pathways analyzed by the researchers are usually tightly regulated. In tumor development, however, they become dysfunctional.

The scientists started with a pathway linked to the tumor suppressor gene known as transformation-related protein 53 (Trp53), which encodes another protein known as p53. Mutations of Trp53 are found in a variety of cancers, but its function in female reproduction and other normal physiological processes is not well understood. The role of p53, sometimes referred to as “the guardian angel gene,” is to help preserve genetic stability and prevent mutation.

The researchers wanted to test the importance of uterine p53 in female reproduction, but the availability of suitable mouse models for clinically relevant preterm labor studies is limited. This led Dr. Dey and his team to develop a new mouse model. They generated mice that had the Trp53 gene conditionally deleted in the uterus, causing a deficiency of uterine p53 and removing its influence from the pregnancy process.

The team observed that when the mice mated with fertile males they had normal ovulation, fertilization and embryo implantation. Deficiency of p53, however, activated other signaling pathways in the uterus (involving the proteins pAkt and p21) that set the stage for premature birth.

Activation of pAkt and p21 prompted decidual cells – which surround implanting embryos – to mature too quickly to terminal differentiation and senescence, a state where they can no longer divide. Decidual cells are supposed to support the fetus and help form the placenta, but in the p53 deficient uteri they didn’t develop properly because of early senescence. This then triggered an enzyme called COX2, which stimulated production of a molecule called PGF2α.

COX2-derived PGF2α has been linked in previous literature to smooth muscle contraction and the onset of labor. In the current study, activation of the pathway prompted ill-timed contraction of smooth muscles in the uterus and caused the mice to give early birth. Among the mice generated by the Cincinnati Children’s team, more than 50 percent experienced premature birth and neonatal death of their offspring.

The researchers said their findings are striking because preterm birth can be corrected by oral administration of celecoxib, a drug that inhibits COX2 activity.

Dr. Dey said the study emphasizes the critical role p53 plays in healthy pregnancy and delivery, adding that future prematurity studies should focus more closely on p53 and the reproductive processes it helps control. He also said the mouse model generated by his team will be a valuable tool for studying the pregnancy process and preterm labor in humans.

First author on the study, Yasushi Hirota, MD/PhD, is a member of Dr. Dey’s laboratory. Also actively participating on the study were Takiko Daikoku, Ph.D., and Huirong Xie, Ph.D., both in the Division of Reproductive Sciences at Cincinnati Children’s, and Heather Bradshaw, Ph.D., of the Department of Psychological and Brain Sciences, The Kinsey Institute for Research in Sex (Gender and Reproduction), Indiana University, Bloomington, Ind. Also assisting in the early phases of the study was Susanne Tranguch, Ph.D., a former graduate student in the lab.

Funding support came in part from the National Institutes of Health and Dr. Hirota receives funding support from the Japanese Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad.

Source: Cincinnati Children's Hospital Medical Center

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Genetics

Gene study shows way to help save orangutans

Orangutans are notoriously slow and gentle, and a study of their DNA shows they have evolved in a similar way, researchers reported on Wednesday. The findings, published in the journal Nature, could help…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.